Kinetic and modeling studies of S3-S3' subsites of HIV proteinases. 1992

J Tözsér, and I T Weber, and A Gustchina, and I Bláha, and T D Copeland, and J M Louis, and S Oroszlan
Laboratory of Molecular Virology, National Cancer Institute-Frederick Cancer Research and Development Center, Maryland 21702-1201.

Kinetic analysis and modeling studies of HIV-1 and HIV-2 proteinases were carried out using the oligopeptide substrate [formula: see text] and its analogs containing single amino acid substitutions in P3-P3' positions. The two proteinases acted similarly on the substrates except those having certain hydrophobic amino acids at P2, P1, P2', and P3' positions (Ala, Leu, Met, Phe). Various amino acids seemed to be acceptable at P3 and P3' positions, while the P2 and P2' positions seemed to be more restrictive. Polar uncharged residues resulted in relatively good binding at P3 and P2 positions, while at P2' and P3' positions they gave very high Km values, indicating substantial differences in the respective S and S' subsites of the enzyme. Lys prevented substrate hydrolysis at any of the P2-P2' positions. The large differences for subsite preference at P2 and P2' positions seem to be at least partially due to the different internal interactions of P2 residue with P1', and P2' residue with P1. As expected on the basis of amino acid frequency in the naturally occurring cleavage sites, hydrophobic residues at P1 position resulted in cleavable peptides, while polar and beta-branched amino acids prevented hydrolysis. On the other hand, changing the P1' Pro to other amino acids prevented substrate hydrolysis, even if the substituted amino acid had produced a good substrate in other oligopeptides representing naturally occurring cleavage sites. The results suggest that the subsite specificity of the HIV proteinases may strongly depend on the sequence context of the substrate.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D006868 Hydrolysis The process of cleaving a chemical compound by the addition of a molecule of water.
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013379 Substrate Specificity A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts. Specificities, Substrate,Specificity, Substrate,Substrate Specificities
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015498 HIV-2 An HIV species related to HIV-1 but carrying different antigenic components and with differing nucleic acid composition. It shares serologic reactivity and sequence homology with the simian Lentivirus SIMIAN IMMUNODEFICIENCY VIRUS and infects only T4-lymphocytes expressing the CD4 phenotypic marker. HTLV-IV,Human T-Lymphotropic Virus Type IV,Human immunodeficiency virus 2,LAV-2,HIV-II,Human Immunodeficiency Virus Type 2,Human T Lymphotropic Virus Type IV,Immunodeficiency Virus Type 2, Human,SBL-6669

Related Publications

J Tözsér, and I T Weber, and A Gustchina, and I Bláha, and T D Copeland, and J M Louis, and S Oroszlan
June 1994, The Journal of biological chemistry,
J Tözsér, and I T Weber, and A Gustchina, and I Bláha, and T D Copeland, and J M Louis, and S Oroszlan
November 1993, Archives of biochemistry and biophysics,
J Tözsér, and I T Weber, and A Gustchina, and I Bláha, and T D Copeland, and J M Louis, and S Oroszlan
May 2003, Plant molecular biology,
J Tözsér, and I T Weber, and A Gustchina, and I Bláha, and T D Copeland, and J M Louis, and S Oroszlan
January 1996, Proceedings of the National Academy of Sciences of the United States of America,
J Tözsér, and I T Weber, and A Gustchina, and I Bláha, and T D Copeland, and J M Louis, and S Oroszlan
September 1986, The Biochemical journal,
J Tözsér, and I T Weber, and A Gustchina, and I Bláha, and T D Copeland, and J M Louis, and S Oroszlan
November 2005, Journal of medicinal chemistry,
J Tözsér, and I T Weber, and A Gustchina, and I Bláha, and T D Copeland, and J M Louis, and S Oroszlan
July 1968, Enzymologia,
J Tözsér, and I T Weber, and A Gustchina, and I Bláha, and T D Copeland, and J M Louis, and S Oroszlan
August 1976, Archives of biochemistry and biophysics,
J Tözsér, and I T Weber, and A Gustchina, and I Bláha, and T D Copeland, and J M Louis, and S Oroszlan
November 2009, Bioorganic & medicinal chemistry letters,
J Tözsér, and I T Weber, and A Gustchina, and I Bláha, and T D Copeland, and J M Louis, and S Oroszlan
July 1987, Biochemistry,
Copied contents to your clipboard!